No. 1 Industry Giant Tests Resistance, Buy Zone In Market Correction

No. 1 Industry Giant Tests Resistance, Buy Zone In Market Correction

With earnings due, drug distribution giant AmerisourceBergen shows resilience just below a recent buy zone.